| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 65.350 | 59.748 | 56.895 | 67.058 | 61.070 | 52.313 | 57.772 | 29.185 | 41.722 | 45.828 |
| Total Income - EUR | 65.390 | 59.961 | 56.993 | 67.114 | 61.149 | 52.361 | 57.905 | 29.367 | 41.849 | 45.899 |
| Total Expenses - EUR | 63.114 | 47.107 | 39.282 | 50.937 | 57.474 | 64.304 | 79.170 | 35.328 | 41.905 | 38.602 |
| Gross Profit/Loss - EUR | 2.276 | 12.855 | 17.711 | 16.177 | 3.675 | -11.944 | -21.265 | -5.960 | -56 | 7.297 |
| Net Profit/Loss - EUR | 5 | 11.659 | 17.142 | 15.507 | 3.064 | -12.426 | -21.843 | -6.252 | -473 | 5.423 |
| Employees | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Spytha Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 298 | 148 | 833 | 569 | 1.067 | 639 | 402 | 310 | 309 | 288 |
| Current Assets | 69.179 | 81.805 | 93.482 | 104.168 | 82.374 | 72.022 | 42.980 | 33.578 | 37.966 | 48.995 |
| Inventories | 13.739 | 14.447 | 15.970 | 18.970 | 22.468 | 25.130 | 14.014 | 16.575 | 12.957 | 17.151 |
| Receivables | 26.269 | 16.564 | 20.472 | 21.912 | 18.908 | 13.136 | 18.730 | 13.739 | 22.863 | 26.172 |
| Cash | 29.171 | 50.794 | 57.040 | 63.285 | 40.998 | 33.757 | 10.236 | 3.264 | 2.146 | 5.672 |
| Shareholders Funds | 18.855 | 30.322 | 17.194 | 32.385 | 34.822 | 16.568 | -5.643 | -11.913 | -12.350 | -6.858 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 50.622 | 51.631 | 77.121 | 72.352 | 48.618 | 56.094 | 49.025 | 45.801 | 50.625 | 56.141 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Spytha Med S.r.l.